MedPath

MoxCV 625

Brand Name: MoxCV 625

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-14076

Dosage Form

Film-Coated Tablet

Issuance Date

June 5, 2024

Expiry Date

June 14, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength625 mg
PackagingAlu/Clear PVC-PVDC Blister Pack x 10's (Box of 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial (Penicillin/Beta-lactamase inhibitor)
A
Application
Initial (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform